Each active clinical trial scoped to transition would need its own strategic roadmap, where stakeholders — sponsors, CROs, and sites — were on the same page at every step, including the ...
The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...
TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical development process, will ...